Wedbush Reiterates an 'Outperform' on Emergent BioSolutions (EBS); 5 Year, 44.75 Million Doses, $1.25 Billion BioThrax Contract
Go back to Wedbush Reiterates an 'Outperform' on Emergent BioSolutions (EBS); 5 Year, 44.75 Million Doses, $1.25 Billion BioThrax Contract| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 4.59 +0.10 (2.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.49 | 52 Week High | $44.38 | |||
| Open | $4.50 | 52 Week Low | $24.47 | |||
| Day High | $4.67 | P/E | 229.50 | |||
| Day Low | $4.45 | EPS | $0.02 | |||
| Volume | 1,095,418 | |||||
